Telogen Effluvium in SARS-CoV-2 Infection: Histological Aspects

    March 2023 in “ Journal of the European Academy of Dermatology and Venereology ”
    Simone Michelini, Gemma Caro, Marco Di Fraia … Giovanni Pellacani
    Studysummary This letter to the editor explores histological aspects of telogen effluvium in SARS-CoV-2 infection but reports no new clinical findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 6

    1. The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series Journal of Clinical Medicine · 2022
    2. Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management JAAD International · 2021
    3. Telogen Effluvium: A Review of the Science and Current Obstacles Journal of Dermatological Science · 2021
    4. Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms Skin appendage disorders · 2021
    5. SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study Journal of the European Academy of Dermatology and Venereology · 2020
    6. Telogen Effluvium: A Review Journal of Clinical and Diagnostic Research · 2015